Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.

Pennel KAF., Hatthakarnkul P., Wood CS., Lian G-Y., Al-Badran SSF., Quinn JA., Legrini A., Inthagard J., Alexander PG., van Wyk H., Kurniawan A., Hashmi U., Gillespie MA., Mills M., Ammar A., Hay J., Andersen D., Nixon C., Rebus S., Chang DK., Kelly C., Harkin A., Graham J., Church D., Tomlinson I., Saunders M., Iveson T., Lannagan TRM., Jackstadt R., Maka N., Horgan PG., Roxburgh CSD., Sansom OJ., McMillan DC., Steele CW., Jamieson NB., Park JH., Roseweir AK., Edwards J.

DOI

10.1186/s13046-026-03811-6

Type

Journal article

Publication Date

2026-08-01T00:00:00+00:00

Volume

45

Addresses

School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK. kathryn.pennel@glasgow.ac.uk.

Permalink More information Close